Innovate UK-funded biotech company accelerates cheaper drug and vaccine manufacture after biocomputer breakthrough

An Innovate UK-backed biotech firm has achieved a pioneering biocomputer breakthrough which is accelerating the event and manufacture of cheaper medicine and vaccines.

BiologIC Applied sciences, inventor of the world’s first biocomputer, has developed 3D printed ‘lab-on-a-chip’ platforms – miniaturised units that combine a number of laboratory capabilities onto a single chip.

These allow quicker, extra environment friendly, and cost-effective evaluation of organic samples, with functions starting from drug testing to point-of-care diagnostics.

Due to Evaluation for Innovators (A4I), a grant funding programme run by Innovate UK, the UK’s innovation company, BiologIC was capable of entry the experience and superior tools of the Nationwide Measurement Laboratory (NML) hosted at LGC.

In consequence the Cambridge-based firm has achieved a large leap in its understanding of how the plastic supplies utilized in 3D printing the chips work together with organic functions.

It’s now capable of exhibit better biocompatibility and stability of its ‘lab-on-a-chip’ which suggests pharmaceutical producers and Contract, Design and Manufacturing Organisations (CDMOs) can now pace up the work wanted earlier than creating minimal viable merchandise, which can finally result in quicker time-to-market and cheaper medicine and vaccines.

Commenting on BiologIC’s expertise of the A4I programme, Dr Colin Barker, Chief Scientific Officer at BiologIC Applied sciences, mentioned: “With out entry to the high-end analytics, and, extra critically, the world class experience at NML made doable by the A4I funding, it will seemingly have taken us a number of years to realize the identical insights.

“We’ve already taken the educational we’ve gained from the grant and utilized it in actual time. We’ve got a number of lively initiatives, the place we have now immediately utilized our new data to enhance buyer outcomes. This grant immediately led to a rise in our understanding, which has had an instantaneous impression, and better business success.”

For BiologIC to help its clients in creating and manufacturing high-quality organic merchandise, it needed to first perceive the chemical interactions between the 3D printed supplies and organic samples.

“By the character of them being 3D printable supplies, they’re very reactive,” Barker defined. “And so, a part of Biologic’s proprietary know-how is easy methods to take these supplies and deal with them to make them biocompatible. However that’s a really complicated, very gradual course of.”

However the pioneering expertise firm – which has been taking merchandise to market since 2020 – didn’t have the funds or particular experience required for full investigation of those interactions.

“Our clients are attempting to supply superior biology merchandise at scale with strong reproducibility,” Barker added. “The better understanding of our supplies by the A4I grant permits us to standardise and streamline our manufacturing methodologies, delivering reproducible outcomes at a decrease value.

“Personalised medicines by their nature don’t have economies of scale, and value tags can run into hundreds of thousands of kilos per affected person. The BiologIC platform offers the paradigm shift in automation applied sciences required to allow disruptive economics and democratise entry to those new therapies.”

The BiologIC platform is already producing worth for superior builders at buyer websites. The BiologIC workforce works carefully with clients to create customized configurations of its platform, addressing buyer challenges together with rising yield, course of robustness and scale.

Evaluation for Innovators (A4I), run by Innovate UK, the UK’s innovation company, helps companies entry cutting-edge R&D and experience of expertise and tools at 9 nationwide measurement centres throughout the nation. The grant funding can also be prolonged to all or a number of the challenge prices.
Simon Yarwood, Data Switch Supervisor – Industrial Applied sciences, A4I at Innovate UK KTN, mentioned: “The transformation of BiologIC is one more success story generated by A4I. It’s an efficient demonstration of how we empower corporations to spice up their productiveness and their competitiveness by fixing troublesome technical analysis-type issues that possibly they’ve been battling with for a while.

“And we introduce them to some distinctive associate organisations, like NML, who’ve world class expertise and distinctive amenities. That enables them to take a look at issues in a brand new means, after which assist remedy them.”

A4I has been working since 2016 and brings collectively 9 nationwide centres of excellence in measurement, tackling challenges affecting current processes, services or products. Throughout 9 rounds of funding, it has supported over 250 corporations leading to over £600M of profit for these companies, corresponding to elevated productiveness and turnover, lowered waste, and the creation of latest and upskilled jobs.

Back To Top